Do angiotensin receptor blockers prevent myocardial infarctions as well as other initial therapies?
Current Opinion in Cardiology, 06/26/2012
Singh A et al. – The definitive answer of whether ARBs are effective, if at all, in preventing myocardial infarction (MI) remains difficult to parse out. Current evidence from newer clinical trials and comprehensive meta–analyses suggests that ARBs, while effective antihypertensive agents that protect against risk of stroke, renal disease, diabetes, and heart failure, are likely to have a neutral effect upon reduction of MI when compared with other antihypertensive agent